As the Delta virus is raging fiercely, another COVID-19 variant has attracted the attention of the World Health Organization (WHO). Lambda, a variant of the virus first known as C.37, was first discovered in Peru at the end of last year and has now spread to 27 countries including the United Kingdom.
According to data from the World Health Organization, 82% of the new confirmed cases of COVID-19 in Peru in May and June were infected with Lambda virus; in Peru’s neighboring Chile, Lambda virus accounted for almost one-third of the new cases.
When the medical community first noticed the virus, there was only 1 case in 200 samples.
However, when the time came to March, Lambda accounted for about 50% of the sample of Lima, the capital of Peru, and now the proportion has come to about 80%. This shows that this virus is more infectious than other variants.
But it is worth noting that, as far as the current situation is concerned, scientists are still unable to determine whether Lambda’s mutation is the cause of its more infectiousness.
One reason is that it has a rather unusual set of mutations compared to other virus variants.
However, according to the investigation of the British Public Health Department, there is no evidence that the Lambda variant will cause more serious diseases or reduce the effectiveness of the vaccine.
